Disorders of the Female Reproductive System¶
Chapter 404 | Part 12: Endocrinology and Metabolism
KEY CLINICAL POINTS¶
- The female reproductive system integrates hormonal signals from the hypothalamus, pituitary, and ovary to regulate follicle development, ovulation, and endometrial preparation for implantation.
- Ovarian follicle development involves dynamic interactions between germ cells and somatic cells, regulated by FSH, LH, and steroidogenic enzymes.
- Precocious puberty in girls is defined as secondary sexual characteristics before age 8, with central (GnRH-dependent) and peripheral (GnRH-independent) causes.
- Delayed puberty is diagnosed when secondary sexual characteristics are absent by age 13, often due to hypothalamic dysfunction, ovarian failure, or systemic illnesses.
- Hormonal feedback loops (estrogen/progesterone) and GnRH pulsatility are critical for regulating the menstrual cycle and reproductive function.
1. DEFINITION & OVERVIEW¶
The female reproductive system regulates hormonal changes responsible for puberty and adult reproductive function. Normal reproductive function requires dynamic integration of hypothalamic-pituitary-ovarian signals, resulting in cyclic follicle development, ovulation, and endometrial preparation for implantation.
Table 404-1: Differential Diagnosis of Precocious Puberty¶
| CENTRAL (GnRH DEPENDENT) | PERIPHERAL (GnRH INDEPENDENT) |
|---|---|
| Idiopathic | Congenital adrenal hyperplasia |
| CNS tumors | Estrogen-producing tumors |
| Hamartomas | Adrenal tumors |
| Astrocytomas | Ovarian tumors |
| Adenomyomas | Gonadotropin/hCG-producing tumors |
| Gliomas | Exogenous exposure to estrogen or androgen |
| Germinomas | McCune-Albright syndrome |
| CNS infection | Aromatase excess syndrome |
| Genetic (KISS1, KISS1R, MKRN3, DLK1) | Head trauma |
| Head trauma | Iatrogenic |
| Iatrogenic | Radiation |
| CENTRAL (GnRH DEPENDENT) | PERIPHERAL (GnRH INDEPENDENT) |
|---|---|
| Radiation | Chemotherapy |
| Chemotherapy | Surgical |
| Surgical | CNS malformation |
| CNS malformation | Arachnoid or suprasellar cysts |
| Arachnoid or suprasellar cysts | Septo-optic dysplasia |
| Septo-optic dysplasia | Hydrocephalus |
1.1 Ovarian Development and Follicle Formation¶
Oogonia (germ cells) proliferate during fetal life, reaching ~6–7 million by 20 weeks gestation. Postnatally, primordial follicles (1–2 million) remain, with progressive loss through atresia. Follicle maturation involves theca and granulosa cell interactions, steroidogenesis, and hormone secretion.
1.2 Hormonal Regulation¶
FSH and LH drive follicle recruitment, growth, and ovulation. Estrogen (estradiol) and progesterone regulate endometrial changes, negative feedback on GnRH, and menstrual cycle phases. Inhibins and activins modulate gonadotropin secretion.
2. EPIDEMIOLOGY¶
Menarche occurs at ~12.5 years in the U.S., with genetic factors accounting for 50–80% of heritability. Premature adrenarche (DHEA) and thelarche (breast development) occur earlier in Black girls. Obesity correlates with earlier thelarche but not menarche. Turner syndrome (45,X) accounts for ~10% of delayed puberty cases.
2.1 Puberty Timing¶
Average age of menarche: 12.5 years. Premature adrenarche (DHEA) may occur before 2 years. Obesity is linked to earlier thelarche but not menarche. Delayed puberty affects ~10% of girls, with 25–40% due to ovarian dysfunction.
2.2 Risk Factors¶
Obesity, malnutrition, chronic illnesses (celiac disease, hypothyroidism), and genetic mutations (KAL1, MKRN3) increase risk. Exogenous estrogens (lavender/tea-tree oil) and tumors (germinomas) may cause precocious puberty.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Ovarian function depends on hypothalamic GnRH pulsatility, pituitary FSH/LH, and steroidogenesis. Precocious puberty may result from central (GnRH activation) or peripheral (gonadal steroid excess) causes. Delayed puberty involves hypothalamic dysfunction, ovarian failure, or systemic illness.
Table 404-2: Evaluation of Precocious and Delayed Puberty¶
| PRECOCIOUS | DELAYED | |
|---|---|---|
| Initial Screening Tests | History and physical | History and physical |
| Bone age | Bone age |
| PRECOCIOUS | DELAYED | |
|---|---|---|
| Estradiol, testosterone | Estradiol, testosterone | |
| 17-Hydroxyprogesterone | ||
| Complete blood count | Complete blood count | |
| Electrolytes, renal function | Electrolytes, renal function | |
| IGF-1, IGFBP-3 | IGF-1, IGFB,3 | |
| Secondary Tests | Pelvic ultrasound | Pelvic ultrasound |
| b-hCG | b-hCG | |
| ACTH stimulation test | ACTH stimulation test | |
| Celiac disease panel | Celiac disease panel | |
| Karyotype | Karyotype |
3.1 Hormonal Feedback¶
Estrogen and progesterone exert negative feedback on GnRH and pituitary gonadotropins. Inhibin B suppresses FSH, while estradiol induces LH surge preovulation. Progesterone increases basal body temperature and inhibits uterine contractions.
3.2 Genetic Factors¶
Imprinted genes (MKRN3, DLK1) regulate GnRH secretion. Mutations in KAL1, FGFR1, PROK2, and PROKR2 cause Kallmann syndrome. Leptin deficiency or receptor mutations may delay puberty.
4. CLINICAL FEATURES¶
Menstrual cycles become regular within 2–4 years of menarche, averaging 28 days. Anovulatory cycles increase with age, with menopausal bleeding patterns being erratic. Premature adrenarche (DHEA) may occur before 2 years, while premature thelarche (breast development) may precede menarche by ~2 years.
4.1 Menstrual Cycle Phases¶
Follicular phase (2–14 days): Estradiol drives endometrial proliferation. Luteal phase (12–14 days): Progesterone induces secretory changes. Ovulation occurs ~36 h after LH surge, with corpus luteum formation.
4.2 Puberty Signs¶
Adrenarche (pubic/axillary hair, DHEA), thelarche (breast development), and menarche (first menses) occur sequentially. Premature adrenarche may precede thelarche by 1–2 years.
5. DIFFERENTIAL DIAGNOSIS¶
Precocious puberty: Central (GnRH-dependent) vs. peripheral (GnRH-independent) causes. Delayed puberty: Hypothalamic dysfunction, ovarian failure, or systemic illness. Include congenital adrenal hyperplasia, tumors, and genetic syndromes (Turner, Kallmann).
Table 404-3: Differential Diagnosis of Delayed Puberty¶
| HYPERGONADOTROPIC | HYPOTHALAMIC | GENETIC |
|---|---|---|
| Ovarian | Syndromes | Hypothalamic syndromes |
| Turner’s syndrome | Leptin/leptin receptor | HESX1 (septo-optic dysplasia) |
| Gonadal dysgenesis | PC1 (prohormone convertase) | PC1 (prohormone convertase) |
| Chemotherapy/radiation therapy | IHH and Kallmann’s syndrome | IHH and Kallmann’s syndrome |
| Galactosemia | KAL1, FGF8, FGFR1, NSMF, PROK2, PROKR2, SEM3A, HS6ST1, WDR11, CHD7 | KAL1, FGF8, FGFR1, NSMF, PROK2, PROKR2, SEM3A, HS6ST1, WDR11, CHD7 |
| Autoimmune oophoritis | KISS1, KISS1R, TAC3, TAC3R, GnRH1, GnRHR, and others | KISS1, KISS1R, TAC3, TAC3R, GnRH1, GnRHR, and others |
| Congenital lipoid hyperplasia | Abnormalities of pituitary development/function | Abnormalities of pituitary development/function |
| Steroidogenic enzyme abnormalities | PROP1 | PROP1 |
| 17a-Hydroxylase deficiency | CNS tumors/infiltrative disorders | CNS tumors/infiltrative disorders |
| Aromatase deficiency | Craniopharyngioma | Craniopharyngioma |
| Gonadotropin/receptor mutations | Astrocytoma, germinoma, glioma | Astrocytoma, germinoma, glioma |
| FSHb, LHR, FSHR | Prolactinomas, other pituitary tumors | Prolactinomas, other pituitary tumors |
| Androgen resistance syndrome | Histiocytosis X | Histiocytosis X |
| Chemotherapy/radiation | Chemotherapy/radiation | |
| Functional | Functional | |
| Chronic diseases | Chronic diseases | |
| Malnutrition | Malnutrition | |
| Excessive exercise | Excessive exercise | |
| Eating disorders | Eating disorders |
5.1 Precocious Puberty¶
Central: CNS tumors, genetic mutations (KISS1, MKRN3), head trauma. Peripheral: Exogenous estrogens, adrenal tumors, congenital adrenal hyperplasia.
5.2 Delayed Puberty¶
Hypothalamic: Leptin deficiency, tumors, malnutrition. Ovarian: Turner syndrome, galactosemia, autoimmune oophoritis. Systemic: Celiac disease, hypothyroidism.
6. INVESTIGATIONS & DIAGNOSIS¶
Assess bone age, serum estradiol/testosterone, inhibin B, and gonadotropins. Pelvic ultrasound and MRI evaluate ovarian structure. GnRH stimulation tests confirm hypogonadotropism. Genetic testing for KAL1, MKRN3, and other mutations is indicated in familial cases.
6.1 Laboratory Tests¶
Serum FSH, LH, estradiol, inhibin B, and testosterone. 17-hydroxyprogesterone for congenital adrenal hyperplasia. TSH, prolactin, and IGF-1/IGFBP-3 for systemic illness.
6.2 Imaging¶
Pelvic ultrasound to assess ovarian morphology. Cranial MRI for CNS tumors. Bone age X-ray to evaluate growth velocity.
7. MANAGEMENT & TREATMENT¶
Central precocious puberty: GnRH agonists (leuprolide) to suppress gonadotropins. Peripheral precocious puberty: Aromatase inhibitors (exemestane) or androgen blockers. Delayed puberty: Hormone replacement (estrogen/progesterone) for hypogonadism. Address underlying causes (tumors, malnutrition).
7.1 Precocious Puberty¶
GnRH agonists (leuprolide 0.5–1.0 mg/kg/month) to delay epiphyseal closure. Aromatase inhibitors for peripheral causes. Monitor bone age and psychosocial impact.
7.2 Delayed Puberty¶
Hormone replacement (estrogen/progesterone) for hypogonadism. Treat underlying causes (hypothyroidism, celiac disease). Nutritional counseling for eating disorders.
8. PROGNOSIS & COMPLICATIONS¶
Precocious puberty may lead to short stature due to early epiphyseal closure. Delayed puberty often resolves with hormone therapy. Untreated hypogonadism risks infertility, osteoporosis, and metabolic syndrome. Early diagnosis improves outcomes.
8.1 Complications¶
Short stature, infertility, osteoporosis, and metabolic syndrome in untreated cases. Psychosocial challenges in precocious puberty. Ovarian failure in Turner syndrome.
8.2 Monitoring¶
Regular bone age assessments, hormone levels, and endometrial evaluation. Long-term follow-up for genetic syndromes and systemic illnesses.
9. SPECIAL CONSIDERATIONS¶
Pregnancy: Hormonal changes affect follicle development and endometrial receptivity. Pediatrics: Puberty timing influenced by genetics and nutrition. Elderly: Ovarian function declines with age, increasing menopausal symptoms. Obesity: Linked to earlier thelarche and PCOS.
9.1 Pregnancy¶
Hormonal shifts support implantation and placental development. hCG maintains corpus luteum function. Gestational diabetes and hypertension risk increases.
9.2 Pediatrics¶
Premature adrenarche may predict PCOS. Obesity and malnutrition disrupt pubertal timing. Early intervention for eating disorders.
10. KEY POINTS & CLINICAL PEARLS¶
- Hypothalamic-pituitary-ovarian axis regulates follicle development and menstrual cycles. 2. Precocious puberty requires distinction between central (GnRH-dependent) and peripheral (GnRH-independent) causes. 3. Delayed puberty often resolves with hormone therapy but may indicate underlying systemic illness. 4. Genetic testing is critical for familial cases of precocious or delayed puberty. 5. Early intervention improves outcomes for hormonal imbalances and reproductive health.